Greg Armstrong, MD

Pediatric oncologist & researcher at St. Jude │ Childhood Cancer Survivor Study principal investigator

[Greg Armstrong, MD @GregArmstrongMD]

@StJudeResearch Thanks for having me. This is really great news for survivors, and I'm happy to share it. #stjudechat

[R.Rogers 👩🏻‍🔬 (she/her) 🌈 @BeccaBL2]

.@GregArmstrongMD Yay!! Yes, tailored treatments, controlled dosages, win-win for patients. #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

@BeccaBL2 Thank you! #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

You can read more about the Childhood Cancer Survivor Study in @USATODAYhealth http://t.co/a10wGVtJ90 #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

@BeccaBL2 Importantly, we've seen reduced rate of death due to heart disease in survivors, which is great news! #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

T8: The future of today's cancer survivors is brighter than survivors from earlier decades bc of advances in upfront therapy #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

T7: As soon as they've completed therapy for their primary cancer. Some late effects can happen early... they're not always late #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

T5: we should continue to identify patients with low-risk cancers. #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

T3: The 15-year all-cause mortality has decreased significantly from the 1970s through the 1980s and 90s. #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

@BeccaBL2 Yes, that's right. These findings are from the Childhood Cancer Survivor Study. It was started in 1994. #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

T4: We can do this thru early detection of late effects and intervention studies that reduce the risk of late effects. #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

T4: We need to not only extend their lifespan, but extend their health span #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

T3: Improvement in survival is due to the fact that we've reduced amount of tx a patient would recieve for certain key cancers #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

@vickyyyf Likely the case. The survivors in our study are from U.S. and Canada. #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

T3: We've identified lower mortality rates due to secondary cancers and heart disease. And that's good news for survivors! #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

T3: Good news is that survivors from the 1990s have lower mortality rates and longer lifespans than their predecessors #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

@vickyyyf Through our St. Jude Lifetime Cohort, we are evaluating that on a research basis, including many 30-year survivors #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

@BeccaBL2 You're the shining star! That's exactly what you should do. How has your hometown physician helped with your care? #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

@BeccaBL2 That's great! #stjudechat

[Greg Armstrong, MD @GregArmstrongMD]

@vickyyyf @StJudeResearch We definitely need to raise awareness through research & advocacy. #stjudechat